glp 1 and trt Weight Loss Journey With GLP-1 TRT: Enjoying Progress GLP-1 Receptor Agonists as Treatments

metformin, loop diuretics and proton pump inhibitors) have also been implicated [63,64]

With semaglutide delivering up to 15% weight loss in clinical trials and tirzepatide reaching 20% or more, alongside significant A1C improvements, it is no surprise patch companies want in

If Phase 3 results confirm its safety and efficacy, it could reach the market within the next 12 years

Because of this, many GLP-1 users have experienced nutritional deficiencies, leading to additional health issues (4)

A clinically relevant effect will depend on the extent of PK changes and the therapeutic index of the co-administered oral drug

4 Although these findings are promising, randomized clinical trials are needed to clarify the potential efficacy of GLP-1 RAs for AUD and SUD treatment